Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Lausanne Hospitals | OTHER |
Not provided
Not provided
Not provided
Not provided
A retrospective cohort study to explore the impact of the FIFA World Cup 2022 Qatar on paediatric emergency department attendance at two tertiary centres during unprecedent winter viral epidemics.
Earlier studies have reported contradictory relationship between major sporting events and paediatric emergency department attendance. None were conducted during an epidemic surge. The FIFA football World Cup 2022 was held for the first time in its history during the winter period in the northern hemisphere during unprecedented cumulative waves of respiratory syncitial virus (RSV), influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemics.
This study aims to measure the impact of such a global major sporting events on the pattern of paediatric emergency department use and hospital admissions during a peak epidemic season in 2 tertiary hospitals. The study hypothesis was that major sporting events, even during an epidemic peak, can reduce the number of paediatric emergency department visits compared with periods without a sporting event. Major sporting events could serve as a model for identifying human behaviours and patterns leading to paediatric emergency department misuse, in order to develop public health interventions to better rationalise health-seeking behaviours.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| All participants | Data from electronic medical records of all patients under 16 years of age with medical, surgical and traumatology emergencies attending the paediatric emergency departments during the study period |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| NO intervention | Other | NO intervention |
|
| Measure | Description | Time Frame |
|---|---|---|
| PED visits | Retrospective analysis of number of PED visits (counts). | Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022 |
| Measure | Description | Time Frame |
|---|---|---|
| Triage acuity score | Retrospective analysis of number of PED visits (counts) by triage acuity score (coded using the 5-level Canadian Triage and Acuity Scale (from level 1 [resuscitation] to level 5 [nonurgent]). | Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All patients under 16 years of age with medical, surgical and traumatology emergencies attending each pediatric emergency department during the study period will be included. This also includes transfer cases from other hospitals, as well as those who leave prematurely without being seen.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Johan N Siebert, MD | Geneva Children's Hospital, Geneva University Hospitals, Geneva, Switzerland | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Geneva Children's Hospital | Geneva | Switzerland |
Individual Participant Data will be deidentified and the study investigators will house the data locally on secured servers at the Geneva University Hospitals. The datasets used or analysed during the current trial will be available from the corresponding author upon reasonable request. Only deidentified/anonymised data will be shared.
Not provided
Available from 6 month to 5 years after trial publication.
Not provided
Not provided
| ID | Term |
|---|---|
| D004630 | Emergencies |
| D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| D007251 | Influenza, Human |
| ID | Term |
|---|---|
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D007945 | Leukemia, Lymphoid |
Not provided
Not provided
Not provided
Not provided
Not provided
| Chief complaint |
Retrospective analysis of number of PED visits (counts) by chief complaints. |
| Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022 |
| Main diagnosis | Retrospective analysis of number of PED visits (counts) by main diagnosis (coded using the International Classification of Primary Care, 2nd edition [ICPC-2], and International Statistical Classification of Diseases and Related Health Problems, 10th revision [ICD-10-GM]). | Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022 |
| Audience | Daily television and online media audience collected by the independent, multi-platform Swiss national foundation for media research (Mediapulse AG, Bern, Switzerland). | Analysed retrospectively from October 1st, 2022 to December 31, 2022 |
| RSV incidence | RSV-incidence estimates among children will be obtained from the anonymised Swiss RSV EpiCH multicentre database. RSV testing uses reverse-transcription polymerase chain reaction or rapid antigen test at the point of care. | Analysed retrospectively from October 1st, 2022 to December 31, 2022 |
| Influenza incidence | Influenza-incidence among children visiting the PED during the study period will be obtained from the institutional electronic medical records. RSV testing on nasopharyngeal swabs uses reverse-transcription polymerase chain reaction at the point of care. | Analysed retrospectively from October 1st, 2022 to December 31, 2022 |
| SARS-CoV-2 incidence | SARS-CoV-2-incidence among children visiting the PED during the study period will be obtained from the institutional electronic medical records. SARS-CoV-2 testing on nasopharyngeal swabs uses reverse-transcription polymerase chain reaction at the point of care. | Analysed retrospectively from October 1st, 2022 to December 31, 2022 |
| D007938 | Leukemia |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D008232 | Lymphoproliferative Disorders |
| D008206 | Lymphatic Diseases |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D009976 | Orthomyxoviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D012140 | Respiratory Tract Diseases |